Search results for “Hypertensive cardiovascular disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 53 patents, we discovered top 19 key players by total patent application. F. Hoffmann-La Roche Ltd., Encysive Pharmaceuticals, Inc., SphingoTec GmbH are dominant in this area. They take 37.74% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 12
Encysive Pharmaceuticals, Inc.
Texas, United States
Patent: 4
SphingoTec GmbH
Brandenburg, Germany
Patent: 4
Merck Patent GmbH
Hessen, Germany
Patent: 4
Nutricia NV
Zuid-Holland, Netherlands
Patent: 4
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
Mars, Inc.
Virginia, United States
Patent: 3
Smithkline Beckman Corp
Pennsylvania, United States
Patent: 2
Sankyo Co., Ltd.
Tokyo-to, Japan
Patent: 1
Pharmacia Corp.
New Jersey, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 2 start-ups by total patent application.
Human Longevity, Inc.
California, United States
Patent: 1
STARTUP
Rivus Pharmaceuticals, Inc.
Virginia, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 12 patents applied in the last 5 years. We discover 7 most active companies in this area. The fast-growing Suzhou Yiran Biotechnology Co., Ltd., SphingoTec GmbH, West Anhui University take 25.00% of patent filing during this period.
Suzhou Yiran Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
SphingoTec GmbH
Brandenburg, Germany
Patent: 1
West Anhui University
Anhui Sheng, China
Patent: 1
STARTUP
Rivus Pharmaceuticals, Inc.
Virginia, United States
Patent: 1
Jiangnan University
Jiangsu Sheng, China
Patent: 1
Human Longevity, Inc.
California, United States
Patent: 1
Zhejiang University
Zhejiang Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 12 patents in last 5 years, we discover 6 new entrants. Suzhou Yiran Biotechnology Co., Ltd., West Anhui University, Rivus Pharmaceuticals, Inc. are the most active new entrants in this area.
Suzhou Yiran Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
West Anhui University
Anhui Sheng, China
Patent: 1
STARTUP
Rivus Pharmaceuticals, Inc.
Virginia, United States
Patent: 1
Jiangnan University
Jiangsu Sheng, China
Patent: 1
Human Longevity, Inc.
California, United States
Patent: 1
Zhejiang University
Zhejiang Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 6 patents, we discovered top 4 universities and scientific research institutions by total patent application. Zhejiang University, Universidade Federal de Minas Gerais, Jiangnan University are dominant in this area. They take 50.00% of the total patent filing.
Zhejiang University
Zhejiang Sheng, China
Patent: 1
Universidade Federal de Minas Gerais
Minas Gerais, Brazil
Patent: 1
Jiangnan University
Jiangsu Sheng, China
Patent: 1
West Anhui University
Anhui Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: